Li, L. (2022) “Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies”, Acta Oncologica, 61(11), pp. 1347–1353. doi: 10.1080/0284186X.2022.2132116.